Package Leaflet: Information for the User
Zyllt 75 mg film-coated tablets EFG
clopidogrel
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information:
Zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet agents. Platelets are very small cells in the blood that clump together to form blood clots. Antiplatelet agents prevent this clumping, reducing the risk of blood clots (a process called thrombosis).
Zyllt is given to adults to prevent blood clots (thrombi) in blood vessels (arteries) that have become hardened (a process known as atherothrombosis), which can lead to atherothrombotic events (such as stroke, myocardial infarction, or death).
You have been prescribed Zyllt to help prevent blood clots and reduce the risk of these serious events because:
you have an irregular heartbeat, a condition called "atrial fibrillation", and you cannot take medicines known as "oral anticoagulants" (vitamin K antagonists) that prevent the formation of new clots and prevent the growth of existing clots. You will have been told that "oral anticoagulants" are more effective than acetylsalicylic acid or the combined use of Zyllt and acetylsalicylic acid for this condition. Your doctor will have prescribed Zyllt plus acetylsalicylic acid if you cannot take "oral anticoagulants" and do not have a risk of severe bleeding.
Do not take Zyllt
If you think any of these apply to you, or if you are unsure, consult your doctor before taking Zyllt.
Warnings and precautions
Before starting treatment with Zyllt, inform your doctor if you are in any of the following situations:
During treatment with Zyllt:
Children and adolescents
This medicine should not be given to children because it is not effective.
Other medicines and Zyllt
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
Some medicines may affect the use of Zyllt or vice versa.
You must specifically tell your doctor if you are taking:
If you have had severe chest pain (unstable angina or myocardial infarction), you may have been prescribed Zyllt in combination with acetylsalicylic acid, a substance found in many medicines used to relieve pain and reduce fever. A dose of acetylsalicylic acid given occasionally (not exceeding 1,000 mg in 24 hours) should not cause any problems, but prolonged use in other circumstances should be discussed with your doctor.
Taking Zyllt with food and drinks
Zyllt can be taken with or without food.
Pregnancy and breastfeeding
It is preferable not to take this medicine during pregnancy.
If you are pregnant or think you may be pregnant, you must inform your doctor or pharmacist before taking Zyllt. If you become pregnant while taking Zyllt, consult your doctor immediately, as it is not recommended to take clopidogrel during pregnancy.
You should not breastfeed while taking this medicine.
If you are breastfeeding or plan to breastfeed, inform your doctor before taking this medicine.
Consult your doctor or pharmacist before using any medicine.
Driving and using machines
Zyllt is unlikely to affect your ability to drive or use machines.
Zyllt contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult him before taking this medicine.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The recommended dose, even for patients with a condition called "atrial fibrillation" (an irregular heartbeat), is one 75 mg Zyllt tablet per day, taken orally with or without food and at the same time each day.
If you have had severe chest pain (unstable angina or myocardial infarction), your doctor may prescribe 300 mg of Zyllt (4 tablets of 75 mg) to be taken once at the start of treatment. After that, the recommended dose is one 75 mg Zyllt tablet per day as described above.
You should take Zyllt for as long as your doctor continues to prescribe it.
If you take more Zyllt than you should
Contact your doctor or go to the nearest hospital emergency department, as there is a higher risk of bleeding.
If you forget to take Zyllt
If you forget to take a dose of Zyllt, but remember before 12 hours have passed since the time you should have taken the medicine, take the tablet immediately and the next one at the usual time.
If you forget for more than 12 hours, simply take the next dose at the usual time. Do not take a double dose to make up for a forgotten tablet.
If you stop taking Zyllt
Do not stop your treatment unless your doctor tells you to. Consult your doctor or pharmacist before stopping this medicine.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Consult your doctor immediately if you experience:
The most common side effect reported with Zyllt is bleeding.
Bleeding may occur in the stomach or intestine, bruising, bleeding (abnormal bleeding or bruising under the skin), nosebleeds, blood in urine. A small number of cases of bleeding in the blood vessels of the eyes, intracranial bleeding, pulmonary bleeding, or joint bleeding have also been reported.
If you experience prolonged bleeding while taking Zyllt
If you cut or injure yourself, the bleeding may take a little longer than usual to stop. This is related to the mechanism of action of the medicine, as it prevents the blood from forming clots. For minor cuts or injuries, such as cutting yourself while shaving, this is usually not a problem. However, if you are concerned about your bleeding, consult your doctor immediately (see section 2 "Warnings and precautions").
Other side effects include:
Common side effects (may affect up to 1 in 10 people):
Diarrhea, abdominal pain, indigestion, or heartburn.
Uncommon side effects (may affect up to 1 in 100 people):
Headache, stomach ulcer, vomiting, nausea, constipation, excess gas in the stomach or intestine, rash, itching, dizziness, tingling, and numbness.
Rare side effects (may affect up to 1 in 1,000 people):
Dizziness, breast enlargement in men.
Very rare side effects (may affect up to 1 in 10,000 people):
Jaundice; severe abdominal pain with or without back pain; fever, difficulty breathing, sometimes associated with cough; generalized allergic reactions (such as a feeling of heat with sudden general discomfort leading to fainting); swelling of the mouth; blisters on the skin; skin allergy; inflammation of the mouth mucosa (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscle pain; changes in taste or loss of taste of food.
Side effects with unknown frequency (cannot be estimated from the available data): Hypersensitivity reactions with chest or abdominal pain, persistent symptoms of low blood sugar.
Your doctor may also observe changes in the results of your blood or urine tests.
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report side effects directly through the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date is the last day of the month shown.
Store in the original package to protect from light and moisture.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Zyllt Composition
Appearance of Zyllt and Package Contents
Film-coated tablets are pink, round, and slightly convex.
Boxes of 7, 14, 28, 30, 50, 56, 60, 84, 90, and 100 film-coated tablets in blisters.
Marketing Authorization Holder
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Manufacturers
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
KRKA-POLSKA Sp. z o.o., ul. Równolegla 5, 02-235 Warszawa, Poland
KRKA - FARMA d.o.o., V. Holjevca 20/E, 10450 Jastrebarsko, Croatia
You can request more information about this medicinal product by contacting the local representative of the marketing authorization holder:
Belgium KRKA Belgium, SA. Tel: + 32 (0) 487 50 73 62 | Lithuania UAB KRKA Lietuva Tel: + 370 5 236 27 40 |
Bulgaria KRKA Bulgaria EOOD Tel: + 359 (02) 962 34 50 | Luxembourg KRKA Belgium, SA. Tel: +32 (0) 487 50 73 62 (BE) |
Czech Republic KRKA CR, s.r.o. Tel: + 420 (0) 221 115 150 | Hungary KRKA Magyarország Kereskedelmi Kft. Tel: + 36 (1) 355 8490 |
Denmark KRKA Sverige AB Tel: + 46 (0)8 643 67 66 (SE) | Malta
Tel: + 356 21 445 885 |
Germany TAD Pharma GmbH Tel: + 49 (0) 4721 606-0 | Netherlands KRKA Belgium, SA. Tel: + 32 (0) 487 50 73 62 (BE) |
Estonia KRKA, d.d., Novo mesto Eesti filiaal Tel: + 372 (0)6 671 658 | Norway KRKA Sverige AB Tel: + 46 (0)8 643 67 66 (SE) |
Greece QUALIA PHARMA S.A. Tel: + 30 210 6256177 | Austria KRKA Pharma GmbH, Wien Tel: + 43 (0)1 66 24 300 |
Spain KRKA Farmacéutica, S.L. Tel: + 34 911 61 03 81 | Poland KRKA-POLSKA Sp. z o.o. Tel: + 48 (0)22 573 7500 |
France KRKA France Eurl Tel: + 33 (0)1 57 40 82 25 | Portugal KRKA Farmacêutica, Sociedade Unipessoal Lda. Tel: + 351 (0)21 46 43 650 |
Croatia KRKA – FARMA d.o.o. Tel: + 385 1 6312 100 | Romania KRKA Romania S.R.L., Bucharest Tel: + 4 021 310 66 05 |
Ireland KRKA Pharma Dublin, Ltd. Tel: + 353 1 293 91 80 | Slovenia KRKA, d.d., Novo mesto Tel: + 386 (0) 1 47 51 100 |
Iceland LYFIS ehf. Tel: + 354 534 3500 | Slovakia KRKA Slovensko, s.r.o. Tel: + 421 (0) 2 571 04 501 |
Italy KRKA Farmaceutici Milano S.r.l. Tel: + 39 02 3300 8841 | Finland KRKA Finland Oy Tel: +358 20 754 5330 |
Cyprus Kipa Pharmacal Ltd. Tel: + 357 24 651 882 | Sweden KRKA Sverige AB Tel: + 46 (0)8 643 67 66 (SE) |
Latvia KRKA Latvija SIA Tel: + 371 6 733 86 10 | United Kingdom KRKA UK Ltd. Tel: + 44 (0) 207 400 3352 |
Date of the Last Revision of this Leaflet:
Detailed information on this medicinal product is available on the European Medicines Agency website http://www.ema.europa.eu/.